The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment

Thrombosis Research

Volumn 120, Issue 3, 2007, Pages 353-359

  Alström, Ulrica ^a   Tydén, Hans ^b   Oldgren, Jonas ^a   Siegbahn, Agneta ^a   Ståhle, Elisabeth ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clopidogrel; Flow cytometry; PFA 100; Platelets; Thrombelastograph

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; FIBRINOGEN; PADGEM PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BLOOD CLOTTING PARAMETERS; BLOOD FLOW; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG INHIBITION; EVALUATION; FEMALE; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; STATISTICAL SIGNIFICANCE; THROMBOCYTE; THROMBOELASTOGRAPHY; THROMBOSIS;

AGED; ASPIRIN; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; PROTEIN BINDING; REFERENCE VALUES; THROMBELASTOGRAPHY; TICLOPIDINE; TIME FACTORS;

EID: 34250021592     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.009     Document Type: Article

References (31)

1. Hansson G.K. Inflammation, aterosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Harrington R.A., Becker R.C., Ezekowit M., Meade T.W., O'Connor C.M., Vorchheimer D.A., et al. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Antithrombotic therapy for coronary artery disease. Chest 126 (2004) 5135-5485
3. Antithrombotic Trials Collaboration. Collaborative meta-analys of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 324 (2002) 71-86
4. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
5. Sabatine M.S., Cannon C.P., Gibson M., Lopez-Sendon J.L., Montalescot G., Theroux P., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 12 (2005) 1179-1189
6. The Clopidogrel In Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 7 (2001) 494-502
7. Metha S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
8. Muller C., Büttner H.J., Petersen J., and Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 101 (2000) 590-593
9. Steinhbl S.R., Berger P.B., Mann III J.T., Fry E.T.A., DeLago A., Wilmer C., et al. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy. JAMA 288 (2002) 2411-2420
10. Silber S., Albertsson P., Avilés F.F., Camici P.G., and The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary intervention. Eur Heart J 26 8 (Apr 2005) 804-847
11. Hollopeter G., Jantzen H.-M., Vincent D., Li G., England L., Ramakrishnan V., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409 (2001) 202-297
12. Gum P.A., Kottke-Marchant K., Poggio E.D., Gurm H., Welsh P.A., Brooks L., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88 (2001) 230-235
13. Müller I., Besta F., Schultz C., Massberg S., Schönig A., and Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89 (2003) 783-787
14. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting. Response, variability, drug resistance and the effect of pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
15. Matetzky S., Shenkman B., Guetta V., Shechter M., Bienart R., Goldenberg I., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic event in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
16. Kapetanakis E.I., Medlam D.A., Boyce S.W., Haile E., Hill P.C., Dullum M.K.C., et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?. Eur Heart J 26 (2005) 576-583
17. Chu M.W.A., Wilson S.R., Norvick R.J., Stitt L.W., and Quantz M.A. Does clopidogrel increase blood loss following coronary artery bypass surgery?. Ann Thorac Surg 78 (2004) 1536-1541
18. Ascione R., Ghosh A., Rogers C.A., Cohen A., Monk C., and Angelini G.D. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a world of caution. Ann Thorac Surg 79 (2005) 1210-1216
19. Savcic M., Hauert J., Bachmann F., Wyld P.J., Geudelin B., and Cariou R. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 25 (1999) 15-19
20. Craft R.M., Chavez J.J., Bresee S.J., Wortham D.C., Cohen E., and Carroll R.C. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 143 (2004) 301-309
21. Tanaka K.A., Szlam F., Kelly A.B., Vega D., and Levy J.H. Clopidogrel (Plavix®) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets 15 (2004) 325-332
22. Candroy Y., Bossavy J.P., Thalamas C., Sagnard L., Sakariassen K., and Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 101 (2000) 2823-2828
23. Klinkhardt U., Bauersachs R., Adams J., Graff J., Lindhoff-Last E., and Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73 (2003) 232-241
24. Storey R.F., Judge H.M., Wilcox R.G., and Heptinstall S. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor agonist AR-C69931MX but not aspirin. Thromb Haemost 88 (2002) 488-494
25. Lepäntalo A., Virtanen K.S., Heikkilä J., Wartiovaara U., and Lassila R. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions. Eur Heart J 25 (2004) 476-483
26. Jilma B. Platelet function analyser (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138 (2001) 152-163
27. Geiger J., Teichmann L., Grossmann R., Aktas B., Steigerwald U., Walter U., et al. Monitoring of clopidogrel action: comparison of methods. Clin Chem 51 (2005) 957-965
28. Chen L., Bacey A.W., Cooper J.R., Collar C.D., Vaugin W.K., and Nussmeier N.A. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 (2004) 425-431
29. Gurbel P.A., Bliden K.P., Guyer K., Cho P.W., Zaman K.A., Kreutz R.P., et al. Platelet reactivity in patients and recurrent events post-stenting. JACC 46 (2005) 1820-1826
30. Craft R.M., Chavez J.J., Snider C.C., Muenchen R.A., and Carrol R.C. Comparison of modified thrombelastograph and platelet works whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 145 (2005) 309-315
31. Labarthe B., Theroux P., Angioi M., and Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. JACC 46 (2005) 638-645